Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types
Select products & services (2)
Select solutions
Active Filters (2)
Clear All
1 - 12 of 55 Results
Sort by:
Best Match
Brochure
IVIS Spectrum 2 platform - illumination in focus
Discover the next generation in preclinical optical imaging, the IVIS Spectrum 2 and IVIS SpectruCT 2 systems.
Whitepaper
Deciphering the role of neutrophils in virus-induced respiratory disease
Preclinical imaging of neutrophilic response in viral infection with IVISense™ Neutrophil Elastase fluorescent probes.
Case Study
Assessment of MYC-driven progression of small cell lung cancer
Researchers at Huntsman Cancer Center use GEMM and the Quantum microCT system for evaluating small cell lung cancer.
Literature - Publication Review
Biopolymers Codelivering Engineered T Cells and STING Agonists can Eliminate Heterogenous Tumors
Using the IVIS® Spectrum non-invasive preclinical optical system to quantify tumor-specific T cells responses in NFAT-luciferase transgenic mice.
Case Study
Optical and microCT imaging enables noninvasive monitoring of EBV-induced neuroinvasion
Researchers use optical and microCT imaging to noninvasively monitor EBV-induced neuroinvasion in a mouse model.
Literature - Publication Review
DNA origami elevates the design of multispecific antibodies as cancer therapeutic agents
Publication review highlighting the use of the IVIS™ Lumina X5 optical imaging system and BioLegend Antibodies describe programmable T cell engagers (PTEs), a novel class of agents created with DNA origami, a nanotechnology that allows the precise spatial arrangement of biomolecules. When combined with antibodies, this approach holds great promise to develop specific and effective biomedical nanotherapies for diseases like cancer.
Case Study
A novel mouse model using optical imaging to detect on-target, off-tumor CAR-T cell toxicity
A Novel Mouse Model Using IVIS® Optical Imaging to Detect On-Target, Off-Tumor CAR-T Cell Toxicity.
Brochure
In vivo imaging reagents
IVISbrite™ bioluminescent reagents and IVISense™ fluorescent probes, dyes, and labels optimized for in vivo imaging.
Whitepaper
Genetically engineered PDX models as patient avatars in preclinical evaluation of acute leukemias
Identifying therapeutic targets using gene silencing techniques in PDX models
Application Note
Cell labeling and tracking in vivo using IVISense NIR fluorescent dyes
Track mammalian cells including stem cells, T-cells, macrophages and more in vivo with IVISense™ (VivoTrack) fluorescent labeling dye
Case Study
Assessing murine glioblastoma growth: a comparative study of ultrasound and MRI imaging modalities
Comparison of MRI with the Vega™ ultrasound system and VesselVue™ agent to track glioblastoma growth in a murine model.
Protocol/SOP
Establishing and utilizing a continuous infusion line for preclinical imaging studies.
The purpose of this protocol is to demonstrate how to maintain a continuous flow of contrast agents into the bloodstream to achieve a consistent concentration.
Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.